Greg Tourangeau serves as Executive at Fulcrum Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Greg Tourangeau has executed 4 insider transactions totaling $59.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 7, 2024 involved selling 236 shares valued at $1.8K.
Greg Tourangeau currently holds 11,571 shares of Fulcrum Therapeutics, Inc. (FULC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Greg Tourangeau has been a net seller of FULC stock. They have purchased $0 and sold $59.8K worth of shares.
Greg Tourangeau's most recent insider trade was on May 7, 2024, when they sold 236 shares at $7.76 per share.
Get notified when new Form 4 filings are submitted
| $11.72 |
| Discretionary |
| May 10, 2023 | FULC | $695 | Sale | 210 | $3.31 | Discretionary |
| May 6, 2022 | FULC | $0 | Award | 3,250 | $N/A | Discretionary |